£515.00

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

Price data last checked 62 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 29 days • 29 data points (No recent data available)

Historical
Generating forecast...
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 12 March 2026 19 March 2026 26 March 2026 02 April 2026 09 April 2026

Price Distribution

Price distribution over 29 days • 1 price levels

Days at Price
29 days 0 7 15 22 29 £515 Days at Price

Price Analysis

Most common price: £515 (29 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 29 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
29 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 10 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 14 Apr 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
99% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 11 Jan 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
99% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 14 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States

£520.00 15 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 14 Apr 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
99% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 31 Mar 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
99% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 12 Jan 2026
The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
99% match

The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City

£795.00 15 Apr 2026
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
99% match

The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East

£325.00 13 Dec 2025
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia
99% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia

£325.00 31 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 18 Mar 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancers
99% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancers

£790.00 22 Jan 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in the United States
99% match

The 2023-2028 Outlook for Lung Cancer Screening Software in the United States

£520.00 13 Jan 2026
The 2021-2026 World Outlook for Lung Cancer Therapeutics
99% match

The 2021-2026 World Outlook for Lung Cancer Therapeutics

£795.00 12 Jan 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in India
98% match

The 2023-2028 Outlook for Lung Cancer Screening Software in India

£515.00 23 Jan 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
98% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East

£325.00 25 Mar 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China

£495.00 15 Apr 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan

£495.00 18 Mar 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
98% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 24 Jan 2026